Introduction
Systemic lupus erythematosus (SLE; lupus) is an autoimmune disease that impacts public health, and in females between five to sixty-four years is between the top 20 main causes of mortality (1). SLE manifestations correlated with subsequent immune complex deposition and formation, various autoantibodies, and other immune processes (2, 3). The neurological manifestations are seen in the 25-95% of cases with SLE. Common manifestations include psychosis, cognitive dysfunction, and headache (4, 5). According to one research, most patients have active lupus symptoms that precede transverse myelitis (TM); however, TM may be the first manifestation of lupus (6). TM is a spinal cord inflammatory condition that may present acutely or sub-acutely (7). It is an uncommon condition with an incidence of approximately one to four new cases per million individuals every year (8). TM is histologically defined by immune cell infiltration of the spinal cord, with pathogenesis mediated by various immunological pathways (9). We describe one such case in which TM was the only presentation of SLE.